Clinical Trial Update: A Study of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-006) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for V419 given with Prevnar 13 and RotaTeq; study completed with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Infections
• Virus Diseases

Drugs mentioned

• V419

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Bacterial Infections, Virus Diseases | Phase 3 | Status: COMPLETED | Results posted: 2016-05-02